Metastat is an advanced test to detect specific blood-borne markers that can accurately determine whether a secondary cancerous tumour is likely to develop and its potential location.
During the test, we analyze a sample of a patient’s blood in our state-of-the-art laboratory to analyze, identify, and measure circulating tumor cells (CTCs).
Metastat RGCC is suitable for all patients who have received a confirmed cancer diagnosis. The test can accurately detect the development of secondary cancers or tumors and improve personalized cancer treatments.
How does Metastat work?
- Metastasis is a stage where tumors begin to infiltrate other organs. This Metastat test is designed to detect specific blood-borne markers that can accurately determine whether a secondary cancerous tumor is likely to develop and its potential location.
- By analyzing a blood sample, we meticulously examine and identify Circulating Tumor Cells (CTCs). The test employs a dual approach to scrutinize your blood sample.
- Using Polymerase Chain Reaction (PCR) to gauge specific marker levels and flow cytometry to identify the protein levels of specific genes, this comprehensive analysis ensures precision in evaluating the cancer’s progression.
Why choose the Metastat test?
- It provides comprehensive information on tumor cells using blood-borne markers.
- It provides a timely assessment of secondary cancer or tumor development.
- It paves the way for more tailored and effective cancer treatments for each patient.